Indywidualna Praktyka Lekarska Prof. Dr hab Konrad Rejdak

The research program at Indywidualna Praktyka Lekarska Prof. Dr hab Konrad Rejdak focuses on immune system diseases, specifically targeting chronic inflammatory demyelinating polyneuropathy to assess new immunomodulatory treatments and improve patient disability scores.

• Chronic inflammatory demyelinating polyneuropathy (CIDP)
• Evaluation of novel immunomodulatory agents
• Patient‑reported disability outcomes
• Long‑term efficacy monitoring

By integrating clinical expertise with patient‑centered goals, the site aims to expand therapeutic options for individuals whose standard treatments have failed.

Investigations at the clinic address nervous system diseases, with an emphasis on multiple sclerosis and the development of convenient home‑administration technologies to enhance treatment adherence and quality of life.

• Multiple sclerosis
• On‑body injection system for subcutaneous therapy
• Caregiver‑administered treatment protocols
• Long‑term disability assessment

The work supports innovative delivery methods that enable patients to manage their condition more independently while maintaining clinical effectiveness.